|
Abstract Objective: To analysis the effectiveness and cost of different treatment for cesarean scar pregnancy (CSP) .Methods: From November 2011 to September 2014, 69 patients with CSP in Jiujiang Maternal and Children Health Care Hospital were divided into 3 groups: 13 cases in dilatation and curettage (D and C) group; 20 cases in Methotrexate (MTX) group: MTX+ Calcium Folinate (CF) + D and C; 36 cases in Bilateral Uterine Artery Chemotherapy Embolism (BUACE) group: (BUACE + D and C). The effectiveness and costs of three treatments were compared. Results: (1) The treatment in the three groups all had excellent effectiveness. In D and C group, 2 cases had further treated by BUACE, 1 case had experienced abdominal subtotal hysterectomy because of heavy bleeding, and 2 cases had further treated by MTX + CF. In MTX group, 1 case had further treated by BUACE , and 1 case had been operated of transabdominal scar lesion resection. There was no any case had shocked in BUACE group. Comparing to D and C group or MTX group, the patients in BUACE group were less bleeding and needed less blood transfusion, the hospitalization time was shorter, blood HCG had dropped quicker, which had statistically significant differences (P<0.01). But in the 3 groups, incidence of shock and other adverse events, menstruation recovery time and return to work time were similar, there was no statistical difference (P> 0.05). (2) Comparing to D and C group and MTX group, though BUACE group had the higher cost of hospitalization expenses, the loss of working time and transportation costs were less, which had statistical significant difference (P< 0.01). The total cost and loss of working time had no statistical difference (P > 0.05) among the three groups. Conclusion: BUACE combined with D and C to treat CSP is safe and effective. The total cost is not higher than other treatments.
|
|
|
|
|
|
